{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:46:57Z","timestamp":1791380817971,"version":"4.3.3"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Institutional National Research Service","award":["T32-DK007130-45"],"award-info":[{"award-number":["T32-DK007130-45"]}]},{"name":"Institutional National Research Service","award":["DK-119437"],"award-info":[{"award-number":["DK-119437"]}]},{"name":"Institutional National Research Service","award":["HL-38180"],"award-info":[{"award-number":["HL-38180"]}]},{"name":"Institutional National Research Service","award":["DK-112378"],"award-info":[{"award-number":["DK-112378"]}]},{"DOI":"10.13039\/100007827","name":"American College of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Crohn\u2019s disease (CD) patients have more than double the risk of nonalcoholic fatty liver disease (NAFLD) compared with the general population after considering traditional risk factors. NAFLD remains underappreciated because routine imaging and liver biochemistries are neither sensitive nor specific for the diagnosis. Here we developed a Clinical Prediction Tool for NAFLD in CD (CPN-CD) using readily accessible parameters to diagnose NAFLD, as determined by magnetic resonance proton density fat fraction (PDFF).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 311 consecutive CD patients who underwent magnetic resonance enterography from June 1, 2017, to May 31, 2018, were screened for NAFLD, defined as a PDFF &amp;gt;5.5% after excluding other liver diagnoses. CPN-CD was derived using binary multivariate logistic regression and internally validated with a 10-fold cross-validation. CPN-CD was compared with the Hepatic Steatosis Index (HSI) by the C-statistic and categorical Net Reclassification Improvement (NRI).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CPN-CD included age, sex, ethnicity\/race, serum alanine aminotransferase, body mass index, known cardiometabolic diagnoses, CD duration, and current use of azathioprine\/6-mercaptopurine. At &amp;lt;20% risk, NAFLD could be excluded with a sensitivity of 86% (negative predictive value, 86%). At \u226550% risk, NAFLD was diagnosed with a specificity of 87% (positive predictive value, 75%). CPN-CD exhibited good discrimination (C-statistic 0.85) compared with fair discrimination of the HSI (C-statistic, 0.76). CPN-CD was superior to the HSI by net reclassification improvement (+0.20; P\u2005&amp;lt;\u20050.001) and decision curve analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CPN-CD outperforms HSI in detecting NAFLD in patients with CD. Future directions include external validation, outcome validation, and testing generalizability to patients with ulcerative colitis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izz324","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T07:18:04Z","timestamp":1578381484000},"page":"1917-1925","source":"Crossref","is-referenced-by-count":14,"title":["Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn\u2019s Disease"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6786-0345","authenticated-orcid":false,"given":"Scott","family":"McHenry","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Washington University in Saint Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Tirath","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University in Saint Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mallinckrodt Institute of Radiology, Washington University in Saint Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshika","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of Cincinnati, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avegail G","family":"Flores","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Washington University in Saint Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas O","family":"Davidson","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Washington University in Saint Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J","family":"Fowler","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mallinckrodt Institute of Radiology, Washington University in Saint Louis, St. Louis, Missouri, USA"},{"name":"Department of Radiology, University of California at San Diego, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A","family":"Ciorba","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Washington University in Saint Louis, St. Louis, Missouri, USA"},{"name":"Division of Gastroenterology, University of Cincinnati, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3436-9784","authenticated-orcid":false,"given":"Parakkal","family":"Deepak","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Washington University in Saint Louis, St. Louis, Missouri, USA"},{"name":"Washington University Inflammatory Bowel Diseases Center, Washington University in Saint Louis, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,7]]},"reference":[{"key":"2021060916163146800_CIT0001","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG clinical guideline: preventive care in inflammatory bowel disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am J Gastroenterol."},{"key":"2021060916163146800_CIT0002","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrgastro.2016.181","article-title":"Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes","volume":"14","author":"Singh","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"2021060916163146800_CIT0003","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1097\/MIB.0b013e31829936a4","article-title":"The increasing weight of Crohn\u2019s disease subjects in clinical trials: a hypothesis-generatings time-trend analysis","volume":"19","author":"Moran","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"2021060916163146800_CIT0004","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.3748\/wjg.v22.i34.7727","article-title":"Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: a review article","volume":"22","author":"Chao","year":"2016","journal-title":"World J Gastroenterol."},{"key":"2021060916163146800_CIT0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ibd.21669","article-title":"Changing shape of disease: nonalcoholic fatty liver disease in Crohn\u2019s disease\u2014a case series and review of the literature","volume":"18","author":"McGowan","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"2021060916163146800_CIT0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"2021060916163146800_CIT0007","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.cgh.2019.02.045","article-title":"Crohn\u2019s disease is associated with an increased prevalence of nonalcoholic fatty liver disease: a cross-sectional study using magnetic resonance proton density fat fraction mapping","volume":"17","author":"McHenry","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2021060916163146800_CIT0008","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology."},{"key":"2021060916163146800_CIT0009","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology."},{"key":"2021060916163146800_CIT0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol."},{"key":"2021060916163146800_CIT0011","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.cgh.2018.04.031","article-title":"Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases","volume":"16","author":"Aniwan","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2021060916163146800_CIT0012","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2337\/dc15-0140","article-title":"Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes","volume":"38","author":"Yamazaki","year":"2015","journal-title":"Diabetes Care."},{"key":"2021060916163146800_CIT0013","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cgh.2018.07.006","article-title":"Obesity and weight gain are associated with progression of fibrosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Kim","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2021060916163146800_CIT0014","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ibd\/izy200","article-title":"Screening for nonalcoholic fatty liver disease in inflammatory bowel diseases: a cohort study using transient elastography","volume":"25","author":"Saroli Palumbo","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"2021060916163146800_CIT0015","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/jlts.2002.36740","article-title":"One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation","volume":"8","author":"Ryan","year":"2002","journal-title":"Liver Transpl."},{"key":"2021060916163146800_CIT0016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jhep.2007.02.007","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center","volume":"47","author":"Lee","year":"2007","journal-title":"J Hepatol."},{"key":"2021060916163146800_CIT0017","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1478-3231.2012.02781.x","article-title":"Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography","volume":"32","author":"Myers","year":"2012","journal-title":"Liver Int."},{"key":"2021060916163146800_CIT0018","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology."},{"key":"2021060916163146800_CIT0019","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology."},{"key":"2021060916163146800_CIT0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1148\/radiol.12120896","article-title":"Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis","volume":"267","author":"Tang","year":"2013","journal-title":"Radiology."},{"key":"2021060916163146800_CIT0021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10278-004-1014-6","article-title":"OsiriX: an open-source software for navigating in multidimensional DICOM images","volume":"17","author":"Rosset","year":"2004","journal-title":"J Digit Imaging."},{"key":"2021060916163146800_CIT0022","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"2021060916163146800_CIT0023","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S1481803500013336","article-title":"Understanding receiver operating characteristic (ROC) curves","volume":"8","author":"Fan","year":"2006","journal-title":"CJEM."},{"key":"2021060916163146800_CIT0024","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis."},{"key":"2021060916163146800_CIT0025","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/MIB.0000000000000832","article-title":"Incidence and predictors of nonalcoholic fatty liver disease by serum biomarkers in patients with inflammatory bowel disease","volume":"22","author":"Bessissow","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"2021060916163146800_CIT0026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther."},{"key":"2021060916163146800_CIT0027","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/sim.1844","article-title":"Validation and updating of predictive logistic regression models: a study on sample size and shrinkage","volume":"23","author":"Steyerberg","year":"2004","journal-title":"Stat Med."},{"key":"2021060916163146800_CIT0028","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med."},{"key":"2021060916163146800_CIT0029","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making."},{"key":"2021060916163146800_CIT0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology."},{"key":"2021060916163146800_CIT0031","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology."},{"key":"2021060916163146800_CIT0032","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2021060916163146800_CIT0033","doi-asserted-by":"crossref","DOI":"10.1111\/apt.15446","article-title":"Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study","author":"Choi","year":"2019;50;769\u2013779","journal-title":"Aliment Pharmacol Ther."},{"key":"2021060916163146800_CIT0034","article-title":"Inflammatory bowel disease increases risk of type 2 diabetes in a nationwide cohort study","author":"Jess","year":"","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/26\/12\/1917\/38574652\/izz324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/26\/12\/1917\/38574652\/izz324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T16:26:56Z","timestamp":1623256016000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/26\/12\/1917\/5697435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,1,7]]},"published-print":{"date-parts":[[2020,11,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izz324","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,1,7]]}}}